December 16, 2023

The early and accurate identification of neuromyelitis optica spectrum disorder is integral to the prognosis and reduction of relapses. Treatment and management strategies include immunosuppressive agents, steroids, and novel monoclonal antibodies.
Immunology
Neurology
Neuromyelitis Optica Spectrum Disorder

NMOSD: An Early Diagnosis to Prevent Blindness and Paraplegia

The early and accurate identification of neuromyelitis optica spectrum disorder is integral to the prognosis and reduction of relapses. Treatment and management strategies include immunosuppressive agents, steroids, and novel monoclonal antibodies. Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disorder mainly involving the optic nerve (optic neuritis) and the spinal cord (myelitis). Prompt and early...

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.